<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR14">
 <label>14.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Giri</surname>
    <given-names>RS</given-names>
   </name>
   <name>
    <surname>Thaker</surname>
    <given-names>HM</given-names>
   </name>
   <name>
    <surname>Giordano</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Rogers</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Sudersanam</surname>
    <given-names>V</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Design, synthesis and characterization of novel 2-(2,4disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-kB and AP-1 mediated transcription activation and as potential anti-inflammatory agents</article-title>
  <source>Eur J Medicinal Chem</source>
  <year>2009</year>
  <volume>44</volume>
  <fpage>2184</fpage>
  <lpage>9</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejmech.2008.10.031</pub-id>
 </element-citation>
</ref>
